Crossmark

The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial

Crossref DOI link: https://doi.org/10.1186/s12906-023-04227-x

Published Online: 2023-10-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Foshati, Sahar http://orcid.org/0000-0002-2669-670X
Poursadeghfard, Maryam

Heidari, Zahra

Amani, Reza http://orcid.org/0000-0002-0074-4080
License Information

Text and Data Mining valid from 2023-10-27

Version of Record valid from 2023-10-27
More Information

Article History

Received: 27 June 2023

Accepted: 18 October 2023

First Online: 27 October 2023

Declarations

:

: This trial was done in agreement with the Declaration of Helsinki and its later amendments. It was approved by the Ethics Committee at the Isfahan University of Medical Sciences under the code IR.MUI.RESEARCH.REC.1400.248. Before the enrollment, informed consent was obtained from the participants.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below